Kodiak Sciences (KOD) Non-cash Items (2016 - 2026)
Kodiak Sciences (KOD) reported Non-cash Items of $464.4 million for Q1 2026, up 24381.44% on a YoY basis from N/an in Q1 2025, and up 41.47% quarter-over-quarter from $328.3 million in Q4 2025.
Kodiak Sciences (KOD) Non-cash Items (2016 - 2026) Analysis & Trends
Kodiak Sciences has reported Non-cash Items for 11 years, with the latest figure at $464.4 million in Q1 2026.
- For the quarter ending Q1 2026, Non-cash Items rose 24381.44% year-over-year to $464.4 million; the trailing twelve-month figure through Mar 2026 stood at $464.4 million (up 24381.44% YoY), and the FY2025 full-year result was $328.3 million, up 543.46% from the prior year.
- Non-cash Items for Q1 2026 stood at $464.4 million, up from $328.3 million in the prior quarter.
- The five-year high for Non-cash Items was $464.4 million in Q1 2026, with the low at $342000.0 in Q3 2023.
- Historically, Non-cash Items has averaged $62.2 million across 5 years, with a median of $5.4 million in 2022.
- Annual changes were most pronounced in 2022 — Non-cash Items tumbled 98.26% — and 2026, when it surged 24381.44%.
- Kodiak Sciences' Non-cash Items stood at $5.4 million in 2022, then sank by 82.75% to $933000.0 in 2023, then soared by 5368.17% to $51.0 million in 2024, then surged by 543.46% to $328.3 million in 2025, then soared by 41.47% to $464.4 million in 2026.
- The last three Non-cash Items figures came in at $464.4 million (Q1 2026), $328.3 million (Q4 2025), and $166.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Kodiak Sciences | 1.95 Bn | 1.95 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 464.41 Mn |
| Mar 31, 2026 | 464.41 Mn |
| Dec 31, 2025 | 328.28 Mn |
| Dec 31, 2025 | 328.28 Mn |
| Sep 30, 2025 | 166.58 Mn |
| Sep 30, 2025 | 166.58 Mn |
| Jun 30, 2025 | 5.77 Mn |
| Jun 30, 2025 | 5.77 Mn |
| Mar 31, 2025 | 1.90 Mn |
| Mar 31, 2025 | 1.90 Mn |
| Dec 31, 2024 | 51.02 Mn |
| Dec 31, 2024 | 51.02 Mn |
| Sep 30, 2024 | 1.19 Mn |
| Sep 30, 2024 | 1.19 Mn |
| Jun 30, 2024 | 594,000.00 |
| Jun 30, 2024 | 594,000.00 |
| Mar 31, 2024 | 2.07 Mn |
| Mar 31, 2024 | 2.07 Mn |
| Dec 31, 2023 | 933,000.00 |
| Dec 31, 2023 | 933,000.00 |